+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levetiracetam"

Pediatric Epilepsy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pediatric Epilepsy Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 184 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 276 Pages
  • Global
From
Refractory Status Epilepticus - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Status Epilepticus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Parkinson's Disease Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Parkinson's Disease Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Dravet Syndrome (DS) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
Research Report on China's Levetiracetam Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Levetiracetam Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
From
From
Loading Indicator

Levetiracetam is a medication used to treat epilepsy and other seizure disorders. It is a type of anticonvulsant drug, which works by reducing the abnormal electrical activity in the brain that causes seizures. Levetiracetam is used to treat partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. It is also used to treat Lennox-Gastaut syndrome, a rare form of epilepsy. Levetiracetam is part of the Central Nervous System (CNS) drug market, which includes medications used to treat neurological disorders such as epilepsy, Parkinson's disease, and Alzheimer's disease. The CNS drug market is highly competitive, with many different drugs available to treat the same condition. Companies in the Levetiracetam market include UCB, Inc., Sun Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., and Teva Pharmaceutical Industries Ltd. Show Less Read more